<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-04T23:18:18+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>细数进博会十大“最”，强生、AZ、拜耳等一众药企蓄势待发！</title>
    <updated>2020-11-04T20:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/n4Rx6xi5ZuiLZhAbAXgOjQ</id>
    <link href="https://mp.weixin.qq.com/s/n4Rx6xi5ZuiLZhAbAXgOjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专访阿斯利康中国总经理赖明隆：基层化、线上化、消费者化趋势下，阿斯利康中国要这么做</title>
    <updated>2020-11-04T20:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/tf02ng08ZZ1gnYyAOHH-bQ</id>
    <link href="https://mp.weixin.qq.com/s/tf02ng08ZZ1gnYyAOHH-bQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>转型期还剩多长？创新开启黄金十年！全体医药人关注的年度大会议程首发</title>
    <updated>2020-11-04T20:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/c-hzPUnvzGw8sCR4tgVoyA</id>
    <link href="https://mp.weixin.qq.com/s/c-hzPUnvzGw8sCR4tgVoyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1类新药获批IND，天士力引进国际创新药快速落地</title>
    <updated>2020-11-04T20:13:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/6PTyZ45tSsWD4QApFxUZ2w</id>
    <link href="https://mp.weixin.qq.com/s/6PTyZ45tSsWD4QApFxUZ2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>吴以芳接任复星医药董事长：相信未来5年头部企业一半收入来自创新药，复星医药要比别人快0.01秒</title>
    <updated>2020-11-03T22:36:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/27PZa8R0nmwk2YH_VhRUNg</id>
    <link href="https://mp.weixin.qq.com/s/27PZa8R0nmwk2YH_VhRUNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新官方数据！抗疫成绩单：33个药与疫苗开展临床，4个进入Ⅲ期，进展顺利！</title>
    <updated>2020-11-03T22:36:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/-WFKUqS9XMswaqLmGm2yzg</id>
    <link href="https://mp.weixin.qq.com/s/-WFKUqS9XMswaqLmGm2yzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【倒计时2天】好赛道好平台缺一不可，2020启思会等“你”来！</title>
    <updated>2020-11-03T22:36:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/W94Bqa4_WtGUtvEfpPB53g</id>
    <link href="https://mp.weixin.qq.com/s/W94Bqa4_WtGUtvEfpPB53g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>迈瑞、恒瑞、泰格、石药、华兰生物……上市药企投资价值大PK，你最PICK谁？</title>
    <updated>2020-11-02T19:56:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/XGJPF2XqDtLk5BLehPEHww</id>
    <link href="https://mp.weixin.qq.com/s/XGJPF2XqDtLk5BLehPEHww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PD-1将成新药投资滑铁卢！还有靶点正重蹈PD-1覆辙，涉15家企业</title>
    <updated>2020-11-02T19:56:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/7Ro5ZNH7oisgck9Bwu3LCw</id>
    <link href="https://mp.weixin.qq.com/s/7Ro5ZNH7oisgck9Bwu3LCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞中国研发中心15年，未来要实现两个80%</title>
    <updated>2020-11-02T19:56:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/-ApHg-u9bWWjkDFBRYQWvw</id>
    <link href="https://mp.weixin.qq.com/s/-ApHg-u9bWWjkDFBRYQWvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【倒计时3天】好赛道好平台缺一不可，2020启思会等“你”来！</title>
    <updated>2020-11-02T19:56:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/e3NLucynMpHtDB3Z3VoQdg</id>
    <link href="https://mp.weixin.qq.com/s/e3NLucynMpHtDB3Z3VoQdg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>揭秘日本医药代表制度！佩章上岗只是表象，制度根本改革才是重点！</title>
    <updated>2020-11-01T19:42:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/Tou28XqWif6leAm9XcHPXQ</id>
    <link href="https://mp.weixin.qq.com/s/Tou28XqWif6leAm9XcHPXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧康维视拿下阿柏西普类似药，两周内三家眼科公司引进新产品，本土眼药公司正快速崛起</title>
    <updated>2020-11-01T19:42:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/VuUL7IuuzG4dRarKxZWEUw</id>
    <link href="https://mp.weixin.qq.com/s/VuUL7IuuzG4dRarKxZWEUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又一家企业取得进展！这些年冲刺FDA的中国新药如何了？下一个上市的会是谁？</title>
    <updated>2020-10-31T18:55:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/Cey8q-1ETJmUViBbRQ8xJQ</id>
    <link href="https://mp.weixin.qq.com/s/Cey8q-1ETJmUViBbRQ8xJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二届中医馆医事药事发展高峰论坛 暨中国中药协会中医馆药事联合专业委员会年会会议在苏州召开</title>
    <updated>2020-10-31T18:55:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/g5DLWySdNPwWO33IxssNXw</id>
    <link href="https://mp.weixin.qq.com/s/g5DLWySdNPwWO33IxssNXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>龙头落幕，新秀登场！2020年中国医药上市公司竞争力20强重磅公布</title>
    <updated>2020-10-30T22:12:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/NnClgZu4BRTa88RfxXMWhQ</id>
    <link href="https://mp.weixin.qq.com/s/NnClgZu4BRTa88RfxXMWhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内最大的在线零售药房，又有新动作！</title>
    <updated>2020-10-30T22:12:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/LSLY0sqrX4noBB6qCVIilA</id>
    <link href="https://mp.weixin.qq.com/s/LSLY0sqrX4noBB6qCVIilA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>K药销售255亿元，奥拉帕尼增长60%，瑞德西韦三个月卖59亿，跨国药企三季度纷纷回暖，哪些药将成为新晋重磅？</title>
    <updated>2020-10-30T22:12:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-30:/s/2h7i4lMfXdSMKTymV_vnug</id>
    <link href="https://mp.weixin.qq.com/s/2h7i4lMfXdSMKTymV_vnug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>单季度59亿！新冠成吉利德第二赚钱的治疗领域！下一个进击10亿美元的新冠药物在哪？</title>
    <updated>2020-10-29T20:42:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/WG7zzvxFeVT3rHDBiXok8g</id>
    <link href="https://mp.weixin.qq.com/s/WG7zzvxFeVT3rHDBiXok8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陈启宇辞任复星医药董事长，管理层大调整！</title>
    <updated>2020-10-29T20:42:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-29:/s/kKkeZ-xlHfaYvo3SWiY2rg</id>
    <link href="https://mp.weixin.qq.com/s/kKkeZ-xlHfaYvo3SWiY2rg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>